Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00097513 · ClinicalTrials.gov registry record
National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
A clinical trial, sponsored by Genentech.
- Completed
- Registry status
NCT00097513: Completed study, sponsored by Genentech.
NCT00097513 is a clinical trial that has completed, run by Genentech. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00097513 has completed, sponsored by Genentech.
- COMPLETED
- Registry status
Study Summary
This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty.
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-02 |
| Est. Completion | 2006-06 |
What the finished NCT00097513 record still lists
NCT00097513 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00097513 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00097513 about?
NCT00097513 is a clinical study titled "National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients". This study is a multicenter, open-label, observational, postmarketing surveillance study that will collect information on the use of Genentech GH preparations to treat GH-deficient subjects with optimal GH dosing during puberty.
What is the current status of trial NCT00097513?
This trial is currently completed. The study started on 2003-02. Estimated completion is 2006-06.
Who is sponsoring clinical trial NCT00097513?
This trial is sponsored by Genentech, which has 332 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia